These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1507 related items for PubMed ID: 26279029

  • 1. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP, David S, Alamgeer M, Ganju V.
    Int J Radiat Oncol Biol Phys; 2015 Sep 01; 93(1):111-7. PubMed ID: 26279029
    [Abstract] [Full Text] [Related]

  • 2. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
    Mittal BR, Manohar K, Kashyap R, Bhattacharya A, Singh B, Singh G.
    Hell J Nucl Med; 2011 Sep 01; 14(2):135-9. PubMed ID: 21761015
    [Abstract] [Full Text] [Related]

  • 3. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
    Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T.
    Indian J Med Res; 2018 Mar 01; 147(3):256-262. PubMed ID: 29923514
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging.
    Groheux D, Giacchetti S, Delord M, Hindié E, Vercellino L, Cuvier C, Toubert ME, Merlet P, Hennequin C, Espié M.
    J Nucl Med; 2013 Jan 01; 54(1):5-11. PubMed ID: 23213197
    [Abstract] [Full Text] [Related]

  • 5. Prone Versus Supine Breast FDG-PET/CT for Assessing Locoregional Disease Distribution in Locally Advanced Breast Cancer.
    Abramson RG, Lambert KF, Jones-Jackson LB, Arlinghaus LR, Williams J, Abramson VG, Chakravarthy AB, Yankeelov TE.
    Acad Radiol; 2015 Jul 01; 22(7):853-9. PubMed ID: 25865435
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y, Li P, Zhang H, Shi Y, Wu H, Zhang J, Qian Y, Li C, Yang J.
    Int J Cancer; 2013 Jan 15; 132(2):E37-47. PubMed ID: 22890912
    [Abstract] [Full Text] [Related]

  • 7. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X, Wu F, Han P.
    Hell J Nucl Med; 2014 Jan 15; 17(3):177-83. PubMed ID: 25526754
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Positron emission tomography/computed tomography for lung cancer staging].
    Ladrón de Guevara H D, Furnaro L F, Yévenes A S, Clavero R JM, Lazo P D, Rodríguez D P, Piottante B A, Pefaur D R, Pardo B C.
    Rev Med Chil; 2015 Jan 15; 143(1):22-9. PubMed ID: 25860265
    [Abstract] [Full Text] [Related]

  • 11. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
    van der Hoeven JJ, Krak NC, Hoekstra OS, Comans EF, Boom RP, van Geldere D, Meijer S, van der Wall E, Buter J, Pinedo HM, Teule GJ, Lammertsma AA.
    J Clin Oncol; 2004 Apr 01; 22(7):1253-9. PubMed ID: 15051773
    [Abstract] [Full Text] [Related]

  • 12. Role of 18F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer.
    Manohar K, Mittal BR, Bhoil A, Bhattacharya A, Singh G.
    Nucl Med Commun; 2013 Jun 01; 34(6):557-61. PubMed ID: 23549551
    [Abstract] [Full Text] [Related]

  • 13. Impact of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer.
    Dayes IS, Metser U, Hodgson N, Parpia S, Eisen AF, George R, Blanchette P, Cil TD, Arnaout A, Chan A, Levine MN.
    J Clin Oncol; 2023 Aug 10; 41(23):3909-3916. PubMed ID: 37235845
    [Abstract] [Full Text] [Related]

  • 14. Chest radiography or chest CT plus head and neck CT versus 18F-FDG PET/CT for detection of distant metastasis and synchronous cancer in patients with head and neck cancer.
    Kim Y, Roh JL, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2019 Jan 10; 88():109-114. PubMed ID: 30616780
    [Abstract] [Full Text] [Related]

  • 15. Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer.
    Groheux D, Giacchetti S, Delord M, de Roquancourt A, Merlet P, Hamy AS, Espié M, Hindié E.
    Eur J Nucl Med Mol Imaging; 2015 Mar 10; 42(3):377-85. PubMed ID: 25432784
    [Abstract] [Full Text] [Related]

  • 16. Hybrid 18F-FDG PET/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy.
    Goorts B, Vöö S, van Nijnatten TJA, Kooreman LFS, de Boer M, Keymeulen KBMI, Aarnoutse R, Wildberger JE, Mottaghy FM, Lobbes MBI, Smidt ML.
    Eur J Nucl Med Mol Imaging; 2017 Oct 10; 44(11):1796-1805. PubMed ID: 28600647
    [Abstract] [Full Text] [Related]

  • 17. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
    Fuster D, Duch J, Paredes P, Velasco M, Muñoz M, Santamaría G, Fontanillas M, Pons F.
    J Clin Oncol; 2008 Oct 10; 26(29):4746-51. PubMed ID: 18695254
    [Abstract] [Full Text] [Related]

  • 18. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S.
    BJU Int; 2013 Oct 10; 112(6):729-34. PubMed ID: 23790129
    [Abstract] [Full Text] [Related]

  • 19. Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs.
    Walker GV, Niikura N, Yang W, Rohren E, Valero V, Woodward WA, Alvarez RH, Lucci A, Ueno NT, Buchholz TA.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1381-6. PubMed ID: 22284689
    [Abstract] [Full Text] [Related]

  • 20. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
    Briggs RH, Chowdhury FU, Lodge JP, Scarsbrook AF.
    Clin Radiol; 2011 Dec 01; 66(12):1167-74. PubMed ID: 21867996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.